As of 2026-03-06, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (39.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.64 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -507.9%.
The range of the Relative Valuation is (37.09) - (39.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 25.7x | 23.4x |
| Forward P/E multiples | 21.6x - 23.1x | 22.4x |
| Fair Price | (37.09) - (39.66) | (39.32) |
| Upside | -484.7% - -511.4% | -507.9% |
| Date | P/E |
| 2026-03-04 | -5.91 |
| 2026-03-03 | -5.74 |
| 2026-03-02 | -5.70 |
| 2026-02-27 | -5.98 |
| 2026-02-26 | -5.33 |
| 2026-02-25 | -5.37 |
| 2026-02-24 | -5.35 |
| 2026-02-23 | -5.21 |
| 2026-02-20 | -5.07 |
| 2026-02-19 | -5.16 |
| 2026-02-18 | -5.30 |
| 2026-02-17 | -5.33 |
| 2026-02-13 | -5.20 |
| 2026-02-12 | -5.13 |
| 2026-02-11 | -5.33 |
| 2026-02-10 | -5.24 |
| 2026-02-09 | -5.04 |
| 2026-02-06 | -5.20 |
| 2026-02-05 | -4.75 |
| 2026-02-04 | -4.94 |
| 2026-02-03 | -5.05 |
| 2026-02-02 | -4.75 |
| 2026-01-30 | -4.46 |
| 2026-01-29 | -4.49 |
| 2026-01-28 | -4.46 |
| 2026-01-27 | -4.95 |
| 2026-01-26 | -4.42 |
| 2026-01-23 | -4.33 |
| 2026-01-22 | -4.43 |
| 2026-01-21 | -4.39 |
| 2026-01-20 | -4.32 |
| 2026-01-16 | -4.28 |
| 2026-01-15 | -4.44 |
| 2026-01-14 | -4.70 |
| 2026-01-13 | -4.62 |
| 2026-01-12 | -4.54 |
| 2026-01-09 | -4.65 |
| 2026-01-08 | -4.66 |
| 2026-01-07 | -4.76 |
| 2026-01-06 | -4.76 |
| 2026-01-05 | -4.58 |
| 2026-01-02 | -4.76 |
| 2025-12-31 | -4.93 |
| 2025-12-30 | -4.86 |
| 2025-12-29 | -4.90 |
| 2025-12-26 | -4.99 |
| 2025-12-24 | -5.04 |
| 2025-12-23 | -4.84 |
| 2025-12-22 | -5.01 |
| 2025-12-19 | -4.89 |